The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $11.14 in the prior trading day, Rocket Pharmaceuticals Inc (NASDAQ: RCKT) closed at $10.73, down -3.68%. In other words, the price has decreased by -$3.68 from its previous closing price. On the day, 2.69 million shares were traded. RCKT stock price reached its highest trading level at $10.96 during the session, while it also had its lowest trading level at $10.28.
Ratios:
Our goal is to gain a better understanding of RCKT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.05 and its Current Ratio is at 6.05. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on December 30, 2024, initiated with a Outperform rating and assigned the stock a target price of $32.
On December 18, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $29.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 21 ’24 when Militello John sold 1,224 shares for $13.05 per share. The transaction valued at 15,978 led to the insider holds 49,310 shares of the business.
Patel Kinnari sold 4,588 shares of RCKT for $59,892 on Nov 21 ’24. The insider now owns 392,395 shares after completing the transaction at $13.05 per share. On Nov 21 ’24, another insider, Shah Gaurav, who serves as the CEO of the company, sold 11,091 shares for $13.05 each. As a result, the insider received 144,782 and left with 707,328 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RCKT now has a Market Capitalization of 1184592000 and an Enterprise Value of 769007104.
Stock Price History:
The Beta on a monthly basis for RCKT is 1.01, which has changed by -0.60939693 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, RCKT has reached a high of $31.47, while it has fallen to a 52-week low of $10.88. The 50-Day Moving Average of the stock is -21.73%, while the 200-Day Moving Average is calculated to be -44.39%.
Shares Statistics:
The stock has traded on average 1.16M shares per day over the past 3-months and 1717060 shares per day over the last 10 days, according to various share statistics. A total of 106.34M shares are outstanding, with a floating share count of 96.86M. Insiders hold about 8.91% of the company’s shares, while institutions hold 84.92% stake in the company. Shares short for RCKT as of 1734048000 were 11175314 with a Short Ratio of 11.19, compared to 1731628800 on 11092305. Therefore, it implies a Short% of Shares Outstanding of 11175314 and a Short% of Float of 19.2.
